Oral and Esophageal Brush Biopsy

Aetna considers oral brush biopsy (e.g., OralCDx), esophageal brush biopsy/WATS‑3D (including adjunctive use with forceps biopsies), DNA‑image cytometry, and RNA‑based oral brush assays experimental and investigational and therefore not covered for screening, diagnosis, or surveillance of oral or esophageal precancerous lesions or cancer. No indications are listed as covered because effectiveness has not been established.

"None listed as covered. The policy states the procedures described below are considered experimental and investigational and therefore not established as effective."

Sign up to see full coverage criteria, indications, and limitations.